Brian Concannon

Track

Insider profile

Currently holds a position at Conmed Corp

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 26% 68% 82%
Transactions
10 10% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Conmed Corp July 26, 2013 -
President, Chief Executive Officer, Director Haemonetics Corp April 2, 2009 - Sept. 29, 2015
Brian Concannon's trades of Conmed Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Conmed Corp (CNMD)
Transaction date
Sale
Price
238.55
Quantity 88,389 -36.6%
Value US$663,326
US Conmed Corp (CNMD)
Transaction date
Proposed sale
Price
479.49
Quantity 88,782
Value US$501,911
US Conmed Corp (CNMD)
Transaction date
Sale
Price
294.62
Quantity 48,000 +26.3%
Value US$3,515,417
US Conmed Corp (CNMD)
Transaction date
Proposed sale
Price
125.00
Quantity 2,072
Value US$259,000
US Conmed Corp (CNMD)
Transaction date
Sale
Price
135.06
Quantity 1,843 -17.0%
Value US$248,916
US Conmed Corp (CNMD)
Transaction date
Sale
Price
135.08
Quantity 2,165 -19.4%
Value US$292,448
US Conmed Corp (CNMD)
Transaction date
Sale
Price
135.08
Quantity 2,549 -22.1%
Value US$344,319
US Conmed Corp (CNMD)
Transaction date
Sale
Price
137.91
Quantity 200 -2.2%
Value US$27,582
US Conmed Corp (CNMD)
Transaction date
Sale
Price
136.96
Quantity 4,200 -31.3%
Value US$575,232
US Conmed Corp (CNMD)
Transaction date
Sale
Price
135.09
Quantity 2,027 -13.1%
Value US$273,827
US Conmed Corp (CNMD)
Transaction date
Sale
Price
89.31
Quantity 3,036 -17.9%
Value US$271,145
Transaction date
Purchase
Price
22.68
Quantity 5,000 +inf%
Value US$113,394
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-08 2023-06-07
US Conmed Corp (CNMD)
S Sale
88,389 -36.6%
238.55
US$663,326 		88,389 -36.6% 238.55 US$663,326
2023-06-07 2023-06-07
US Conmed Corp (CNMD)
PrS Proposed sale
88,782
479.49
US$501,911 		88,782 479.49 US$501,911
2023-05-02 2023-05-01
US Conmed Corp (CNMD)
S Sale
48,000 +26.3%
294.62
US$3,515,417 		48,000 +26.3% 294.62 US$3,515,417
2023-05-01 2023-05-01
US Conmed Corp (CNMD)
PrS Proposed sale
2,072
125.00
US$259,000 		2,072 125.00 US$259,000
2022-02-04 2022-02-02
US Conmed Corp (CNMD)
S Sale
1,843 -17.0%
135.06
US$248,916 		1,843 -17.0% 135.06 US$248,916
2022-02-04 2022-02-02
US Conmed Corp (CNMD)
S Sale
2,165 -19.4%
135.08
US$292,448 		2,165 -19.4% 135.08 US$292,448
2022-02-04 2022-02-02
US Conmed Corp (CNMD)
S Sale
2,549 -22.1%
135.08
US$344,319 		2,549 -22.1% 135.08 US$344,319
2022-02-04 2022-02-02
US Conmed Corp (CNMD)
S Sale
200 -2.2%
137.91
US$27,582 		200 -2.2% 137.91 US$27,582
2022-02-04 2022-02-02
US Conmed Corp (CNMD)
S Sale
4,200 -31.3%
136.96
US$575,232 		4,200 -31.3% 136.96 US$575,232
2022-02-04 2022-02-02
US Conmed Corp (CNMD)
S Sale
2,027 -13.1%
135.09
US$273,827 		2,027 -13.1% 135.09 US$273,827
2020-09-14 2020-09-10
US Conmed Corp (CNMD)
S Sale
3,036 -17.9%
89.31
US$271,145 		3,036 -17.9% 89.31 US$271,145
2004-05-03 2003-12-03
B Purchase
5,000 +inf%
22.68
US$113,394 		5,000 +inf% 22.68 US$113,394